DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer’s disease

[1]  Jonathan C. Kagan,et al.  Molecular mechanisms of gasdermin D pore-forming activity , 2023, Nature Immunology.

[2]  M. Peeples,et al.  Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology. , 2023, Journal of immunology.

[3]  Yu-Lin Chen,et al.  Rebalancing TGFβ1/BMP signals in exhausted T cells unlocks responsiveness to immune checkpoint blockade therapy , 2022, Nature Immunology.

[4]  X. Zhuang,et al.  Molecular and spatial signatures of mouse brain aging at single-cell resolution , 2022, Cell.

[5]  A. Webb,et al.  Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Connie M. Ross,et al.  Inflammatory Caspases: Toward a Unified Model for Caspase Activation by Inflammasomes. , 2022, Annual review of immunology.

[7]  G. Nuovo,et al.  Elevated Expression of MiR-17 in Microglia of Alzheimer’s Disease Patients Abrogates Autophagy-Mediated Amyloid-β Degradation , 2021, Frontiers in Immunology.

[8]  C. Nulty,et al.  Regulation, Activation and Function of Caspase-11 during Health and Disease , 2021, International journal of molecular sciences.

[9]  E. D. De Lange,et al.  Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring , 2021, International journal of molecular sciences.

[10]  N. Pivac,et al.  Epigenetics of Alzheimer’s Disease , 2021, Biomolecules.

[11]  Haitao Wen,et al.  Gasdermin D restricts Burkholderia cenocepacia infection in vitro and in vivo , 2021, Scientific reports.

[12]  R. Blesa,et al.  The Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease , 2020, Alzheimer’s Disease: Drug Discovery.

[13]  Xuan Sun,et al.  miR-132 improves the cognitive function of rats with Alzheimer's disease by inhibiting the MAPK1 signal pathway , 2020, Experimental and therapeutic medicine.

[14]  K. Kuter,et al.  Overview of General and Discriminating Markers of Differential Microglia Phenotypes , 2020, Frontiers in Cellular Neuroscience.

[15]  J. Viemari,et al.  Neonatal apneic phenotype in a murine congenital central hypoventilation syndrome model is induced through non‐cell autonomous developmental mechanisms , 2020, Brain pathology.

[16]  Raymond Scott Turner,et al.  Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias , 2020, Frontiers in Neurology.

[17]  S. Bilbo,et al.  Isolation of Microglia from Mouse or Human Tissue , 2020, STAR protocols.

[18]  M. Heneka,et al.  β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia , 2020, Cell reports.

[19]  S. David,et al.  Immune cell regulation of glia during CNS injury and disease , 2020, Nature Reviews Neuroscience.

[20]  Maciej Pietrzak,et al.  BISR-RNAseq: an efficient and scalable RNAseq analysis workflow with interactive report generation , 2019, BMC Bioinformatics.

[21]  A. Amer,et al.  Caspase-11 Mediates Neutrophil Chemotaxis and Extracellular Trap Formation During Acute Gouty Arthritis Through Alteration of Cofilin Phosphorylation , 2019, Front. Immunol..

[22]  L. Buée,et al.  NLRP3 inflammasome activation drives tau pathology , 2019, Nature.

[23]  A. Amer,et al.  Caspase‐11 counteracts mitochondrial ROS‐mediated clearance of Staphylococcus aureus in macrophages , 2019, EMBO reports.

[24]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[25]  Jing Wang,et al.  WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..

[26]  P. Brož,et al.  ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation , 2018, Science.

[27]  W. Zhou,et al.  Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system , 2018, Inflammation and Regeneration.

[28]  R. Ventura,et al.  Epigenetic Inheritance: Concepts, Mechanisms and Perspectives , 2018, Front. Mol. Neurosci..

[29]  A. Amer,et al.  CASP4/caspase-11 promotes autophagosome formation in response to bacterial infection , 2018, Autophagy.

[30]  B. Joseph,et al.  Epigenetics Control Microglia Plasticity , 2018, Front. Cell. Neurosci..

[31]  A. Malik,et al.  The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome‐Induced Inflammation , 2018, Immunity.

[32]  L. Tan,et al.  Microglial priming in Alzheimer's disease. , 2018, Annals of translational medicine.

[33]  Wouter De Coster,et al.  NanoPack: visualizing and processing long-read sequencing data , 2018, bioRxiv.

[34]  M. Heneka,et al.  Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease , 2017, Nature.

[35]  D. Westaway,et al.  Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation , 2017, Journal of Neuroinflammation.

[36]  Heng Li,et al.  Minimap2: pairwise alignment for nucleotide sequences , 2017, Bioinform..

[37]  B. Winblad,et al.  APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.

[38]  Paul G. Thomas,et al.  De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation , 2017, Cell.

[39]  D. Bennett,et al.  A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease , 2017, Alzheimer's & Dementia.

[40]  M. Heneka.  Inflammasome activation and innate immunity in Alzheimer's disease , 2017, Brain pathology.

[41]  C. Bryant,et al.  Inflammasome Priming in Sterile Inflammatory Disease. , 2017, Trends in molecular medicine.

[42]  F. Maxfield,et al.  The endocytic pathway in microglia during health, aging and Alzheimer’s disease , 2016, Ageing Research Reviews.

[43]  Yan Li,et al.  SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation , 2016, PloS one.

[44]  J. Buxbaum,et al.  The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits. , 2016, Human molecular genetics.

[45]  V. Hornung,et al.  Pore formation by GSDMD is the effector mechanism of pyroptosis , 2016, The EMBO journal.

[46]  H. Stahlberg,et al.  GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death , 2016, The EMBO journal.

[47]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[48]  Yaron E. Antebi,et al.  Dynamics of epigenetic regulation at the single-cell level , 2016, Science.

[49]  J. Choi,et al.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis , 2016, Meta gene.

[50]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[51]  J. Ting,et al.  The pathogenic role of the inflammasome in neurodegenerative diseases , 2016, Journal of neurochemistry.

[52]  A. Amer,et al.  Caspase-11 and caspase-1 differentially modulate actin polymerization via RhoA and Slingshot proteins to promote bacterial clearance , 2015, Scientific Reports.

[53]  G. Núñez,et al.  Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. , 2015, Immunity.

[54]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[55]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[56]  P. Hof,et al.  The epigenetics of aging and neurodegeneration , 2015, Progress in Neurobiology.

[57]  M. Wewers,et al.  Inflammasome Priming Is Similar for Francisella Species That Differentially Induce Inflammasome Activation , 2015, PloS one.

[58]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[59]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[60]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[61]  Chris Armoskus,et al.  Identification of sexually dimorphic genes in the neonatal mouse cortex and hippocampus , 2014, Brain Research.

[62]  E. Alnemri,et al.  Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function , 2014, The Journal of Immunology.

[63]  M. Lynch,et al.  Glial Uptake of Amyloid Beta Induces NLRP3 Inflammasome Formation via Cathepsin-Dependent Degradation of NLRP10 , 2014, NeuroMolecular Medicine.

[64]  Faraz A. Sultan.  Dissection of Different Areas from Mouse Hippocampus. , 2013, Bio-protocol.

[65]  Charles D. Schwieters,et al.  Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.

[66]  Shankar Balasubramanian,et al.  Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine , 2013, Nature Protocols.

[67]  L. Tan,et al.  Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy , 2013, Ageing Research Reviews.

[68]  G. Garden.  Epigenetics and the Modulation of Neuroinflammation , 2013, Neurotherapeutics.

[69]  G. Núñez,et al.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.

[70]  Christine E. Becker,et al.  CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation , 2013, Nature Immunology.

[71]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[72]  R. Vassar,et al.  Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation , 2013, Molecular Neurodegeneration.

[73]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[74]  A. Doseff,et al.  Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. , 2012, Immunity.

[75]  H. Jun,et al.  Integrin α5β1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein. , 2012, Immunity.

[76]  K. Ramos,et al.  Epigenetic Therapies for Cancer , 2011 .

[77]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[78]  G. Pfeifer,et al.  Genomic mapping of 5-hydroxymethylcytosine in the human brain , 2011, Nucleic acids research.

[79]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[80]  M. Biel,et al.  Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates , 2010, PloS one.

[81]  Joseph Rogers,et al.  Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation , 2010, Neurobiology of Aging.

[82]  Zachary D. Smith,et al.  Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution , 2010, Nature Methods.

[83]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[84]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[85]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[86]  Gabriel Núñez,et al.  Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.

[87]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[88]  J. Gunn,et al.  Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[89]  M. Wolfe,et al.  Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway* , 2004, Journal of Biological Chemistry.

[90]  E. Masliah,et al.  A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer’s disease , 2004, Neurobiology of Aging.

[91]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[92]  R. Mrak,et al.  Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation , 2001, Neurochemistry International.

[93]  Junying Yuan,et al.  Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE , 1998, Cell.

[94]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[95]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[96]  E. Latz,et al.  The Inflammasome , 2013, Methods in Molecular Biology.

[97]  F. Coppedè.  The Epigenetics of Alzheimer’s Disease , 2012 .